An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

A new at-home self-collection device is taking aim at the screening gap for cervical cancer, and new research, spearheaded by ...

China’s National Medical Products Administration (NMPA) has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, to ...

Lack of insurance, financial instability and even fear are potential reasons women may forego their cervical cancer screening ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

Receiving the results over a smartphone, it's the first change in the pap smear for 80+ years according to the company.

Cervical cancer (cancer of the cervix) is preventable and curable, only if it is detected early and managed effectively .

China NMPA approves Akeso's PD-1/CTLA-4 bispecific antibody cadonilimab for first-line treatment of cervical cancer: Hong Kong Friday, June 6, 2025, 12:00 Hrs [IST] Akeso, Inc., a ...

It's not the first time in budget conference cancer research seems to be taking a backseat to political beefs.

Dr. Beman Khulpateea from Mercy Medical Center talks about cervical cancer screenings.

Cervical cancer is highly preventable, but the disease kills thousands every year. In part, that's because women don't get screened for it regularly.

Around 1,000 participants gathered before dawn on May 25, 2025, at Parqal Mall in ASEANA City, Parañaque, to take part in the “Run Against Cervical Cancer” (RACC). Organized by MSD Philippines and the ...